Hindustan Foods said that it has executed business transfer agreement (BTA) for acquisition of Reckitt Benckiser Health India's (Reckitt) manufacturing facility in Village Sandholi, Baddi, Himachal Pradesh, as a move to further expand its Health Care
PrecisionLife Limited, a global techbio company generating the deepest insights into disease biology to create novel precision medicines in chronic diseases, announced that it has entered into a multi-target discovery and validation partnership...
In this article, let's look into how the healthcare industry is transiting towards preventive care, and explore the key technologies that are enabling it.
To promote discovery of newer therapeutic agents and approaches in the area of inherited rare diseases, the Indian Council of Medical Research (ICMR) has called for proposals on “Therapeutics for inherited rare diseases†from scientists working in...
Takeda Biopharmaceuticals India Private Limited launched Cinryze an innovative injectable prescription medicine for the treatment of hereditary angioedema (HAE) patients. With eight years of global clinical experience proving efficacy and safety,...
The Center of Excellence in 3D bioprinting of Cellink at the Indian Institute of Science (IISc), Bengaluru is expected to advance regenerative medicine, tissue engineering and drug discovery. The operations of the facility have commenced after...
In an effort to improve maternal and child health and to spread awareness and provide equitable and widely accessible healthcare services to eventually eradicate anaemia, the Gurugram District Administration and Deloitte announced the...
Buyout firms Advent International, Baring Private Equity Asia (now owned by EQT), Bain Capital, Blackstone, Carlyle and KKR are among those who have been approached to buy the Fosun-owned Gland Pharma, in what would be one of the largest pharma...
Entod Pharmaceuticals has announced that the company is all set to launch its GLO division to further expand its business. This one-of-a-kind ophthalmic subspeciality division is focused on the treatment of the eye condition glaucoma, which is a lead
The US FDA India office has in principle agreed to the Karnataka drugs control department’s request for ‘observer’ role during the plant audits by the US FDA inspectors. The role as an observer would benefit making the audits more effective. Going fo